Major depression: its recognition and treatment. Part 2. Second-generation and newer antidepressants.
Cohen
L J
LJ
Oklahoma Department of Mental Health and Substance Abuse Services, University of Oklahoma College of Pharmacy, Oklahoma City.
Grothe
D R
DR
D000928:Antidepressive Agents / Q000627:therapeutic use*; D016642:Bupropion / Q000627:therapeutic use; D002997:Clomipramine / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D005260:Female; D005473:Fluoxetine / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014196:Trazodone / Q000627:therapeutic use
D000928:Antidepressive Agents; D016642:Bupropion; D002997:Clomipramine; D005473:Fluoxetine; D008376:Maprotiline; D017367:Selective Serotonin Reuptake Inhibitors; D014196:Trazodone